IDEX（IEX）株式概要
IDEXコーポレーションは、その子会社とともに、米国、北米、欧州、アジア、および国際的に応用ソリューションを提供している。 詳細
報酬
リスク分析
リスクチェックの結果、IEX 、リスクは検出されなかった。
IEX Community Fair Values
Create NarrativeSee what 15 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
IDEX Corporation 競合他社
価格と性能
| 過去の株価 | |
|---|---|
| 現在の株価 | US$208.78 |
| 52週高値 | US$223.85 |
| 52週安値 | US$157.25 |
| ベータ | 1.01 |
| 1ヶ月の変化 | 1.97% |
| 3ヶ月変化 | 0.16% |
| 1年変化 | 16.25% |
| 3年間の変化 | 2.60% |
| 5年間の変化 | -6.23% |
| IPOからの変化 | 7,127.00% |
最新ニュース
Recent updates
ナラティブの更新 • May 14
IEX: Dividend Strength And Buybacks Will Support Returns Going Forward
Analysts have adjusted their price target on IDEX to $237.71 from $222.71, reflecting updated views on revenue growth, profit margins, and future P/E assumptions. What's in the News IDEX Corporation's Board of Directors approved a regular quarterly cash dividend of $0.73 per common share, scheduled to be paid on June 5, 2026, to shareholders of record on May 22, 2026.ナラティブの更新 • Apr 26
IEX: Balanced Outlook As Buybacks And M&A Plans Will Shape Returns
Analysts now project only a slight reduction in IDEX's fair value estimate, with the updated price target moving from about $222.93 to $222.71. This reflects modest adjustments to assumptions around discount rate, revenue growth, profit margin and future P/E.ナラティブの更新 • Apr 12
IEX: Balanced Outlook As Buybacks And M&A Plans Shape Future Returns
Analysts have inched their price target for IDEX lower to about $223 from roughly $224, reflecting slightly revised assumptions on fair value, discount rate and forward P/E, while keeping revenue growth and profit margin expectations broadly unchanged. What's in the News IDEX completed a share repurchase tranche from October 1, 2025 to February 19, 2026, buying 632,280 shares for US$113.1 million, equal to 0.84% of shares under the existing program (Key Developments).ナラティブの更新 • Mar 28
IEX: Ongoing Buybacks And M&A Focus Will Support Future Upside
Analysts have slightly reduced their IDEX price target to $224.29 from $225.08, citing minor model updates to fair value, discount rate, revenue growth, profit margin, and forward P/E assumptions. What's in the News IDEX completed a share repurchase program announced on April 21, 2008, buying back a total of 19,293,107 shares for US$1,623.91m, representing 24.31% of the company (Key Developments).ナラティブの更新 • Mar 14
IEX: Ongoing M&A And Buybacks Will Support Attractive Future Upside
Analysts have raised their price target on IDEX to about $225 from roughly $224, reflecting slightly updated assumptions around the discount rate, revenue growth, profit margin, and forward P/E. What's in the News IDEX is actively pursuing mergers and acquisitions, with management describing the company as about halfway through a multiyear capital deployment cycle focused on building out existing platforms and markets (Key Developments).ナラティブの更新 • Feb 27
IEX: Future CFO And Continued M&A Will Support Steady Outlook
Analysts have kept their average IDEX price target broadly steady around $223.54, with only marginal tweaks to inputs such as the discount rate and assumed future P/E multiple to reflect updated views on the company’s risk profile and valuation framework. What's in the News IDEX is actively pursuing mergers and acquisitions, with management indicating they see themselves around the midpoint of a long term capital deployment cycle and planning additional deals to build out existing market positions, using prior acquisition activity as a reference point for future bolt on targets (Key Developments).ナラティブの更新 • Feb 13
IEX: Future CFO Transition And Ongoing Buybacks Will Support Steady Outlook
Analysts have lifted their price target on IDEX to $223.54 from $198.62, reflecting updated assumptions that include a slightly lower discount rate and modest tweaks to revenue growth, profit margin, and future P/E expectations. What's in the News IDEX completed a share repurchase tranche between October 1, 2025 and December 31, 2025, buying 400,000 shares, or 0.53% of the company, for $75 million under its long running buyback program announced on April 21, 2008 (Key Developments).ナラティブの更新 • Jan 30
IEX: Future CFO Transition And Capital Deployment Will Support Steady Outlook
Analysts have nudged their price target on IDEX higher to about US$199 from roughly US$197, citing updated assumptions that include a slightly lower discount rate, modest tweaks to revenue growth and profit margin expectations, and a marginally higher future P/E estimate. What's in the News IDEX appointed Sean M.Seeking Alpha • Jan 26
IDEX Corporation: Value Creator Is Not Delivering
Summary IDEX Corporation remains a mission-critical industrial solutions provider, but organic growth has stagnated, and recent performance is lackluster. Despite a long track record, IDEX's earnings have been flat near $8/share, with 2025 guidance only modestly improved, and 2026's outlook is cautious. Valuation has compressed from 30x to 24x earnings as shares fell from $235 to $195, but the premium persists without clear operating momentum. I remain cautious, as sustained improvement in organic growth and earnings is needed to justify even the reduced valuation. Read the full article on Seeking Alphaナラティブの更新 • Jan 15
IEX: Future CFO Appointment And Buybacks Will Support Steady Outlook
Analysts have modestly raised their fair value estimate for IDEX to US$197.08 from US$194.62, citing slightly lower assumed revenue growth and profit margins that are offset by a higher future P/E multiple and updated discount rate assumptions. What's in the News IDEX appointed Sean M.分析記事 • Jan 07
These 4 Measures Indicate That IDEX (NYSE:IEX) Is Using Debt Reasonably Well
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...分析記事 • Jul 23
Why IDEX Corporation (NYSE:IEX) Could Be Worth Watching
IDEX Corporation ( NYSE:IEX ) saw a double-digit share price rise of over 10% in the past couple of months on the NYSE...分析記事 • Jul 01
Is IDEX (NYSE:IEX) Using Too Much Debt?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...分析記事 • Jun 15
IDEX's (NYSE:IEX) Returns On Capital Not Reflecting Well On The Business
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Typically, we'll want to notice a...Seeking Alpha • Apr 27
IDEX Corporation: It's Best To Remain Cautious As Earnings Near
Summary IDEX Corporation's stock has fallen 19.3% since last July, but I still rate it a 'hold' due to its high valuation. Revenue and profitability metrics for IDEX have been volatile, with mixed results across its three main business segments. Management's 2025 guidance suggests modest revenue growth and improved earnings, but economic uncertainty and potential tariff impacts remain concerns. Awaiting Q1 2025 results on May 1st, IDEX's stock remains fairly valued compared to peers, but not attractive enough for an upgrade. Read the full article on Seeking AlphaSeeking Alpha • Feb 09
IDEX: A Wonderful Mid-Cap Focused On Long-Term Value Generation
Summary IDEX Corporation is a niche industrial manufacturer with a wide economic moat, producing mission-critical products with significant pricing power and high switching costs. Despite softer 2024 earnings, IDEX remains highly profitable with robust margins and a strong balance sheet. The firm's strategic acquisitions and entrenched customer relationships bolster its market position, ensuring continued growth and competitive insulation. Given the fair valuation and conservative fiscal management, I rate IDEX a Hold, awaiting a larger undervaluation for a potential buy. Read the full article on Seeking AlphaSeeking Alpha • Nov 06
IDEX Corporation: A Demanding Valuation For A Great Business
Summary IDEX Corporation faces sluggish organic growth and slower order intake, yet it maintains a strong long-term value proposition through mission-critical industrial and technology solutions. Despite a solid historical performance, current valuation multiples are demanding, especially given the flattish reported results. The company’s recent $1 billion acquisition of Mott is strategically aligned but comes at a high valuation, reflecting IDEX’s increased reliance on M&A for growth. Shares have risen to $235, driven by optimism, but I remain cautious due to lackluster operating performance and heightened expectations at nearly 30 times earnings. Read the full article on Seeking AlphaSeeking Alpha • Sep 02
IDEX Corp. Q2: Project Delay And Weakness In Life Science
Summary I reiterate a 'Buy' rating for IDEX, with a fair price target of $220 per share, despite near-term headwinds in organic revenue and market softness. IDEX's acquisition of Mott Corporation for $1 billion is strategically favorable, enhancing their applied material science technology and potentially improving overall margins. Project delays and market weakness, particularly in the life science sector, have led to a 4% organic revenue decline and lowered full-year growth guidance. Long-term growth prospects remain strong due to active portfolio management, strategic acquisitions, and anticipated recovery in industrial activities and life science markets by 2025. Read the full article on Seeking AlphaSeeking Alpha • Jul 11
IDEX Corp.: There Are Better Opportunities Out There
Summary IDEX Corporation's revenue grew slightly in 2024, but profitability weakened due to a drop in sales and rising costs. Management remains optimistic about organic revenue growth and adjusted net income for the year. Despite being a high-quality business, IDEX Corporation's shares are not attractively priced, making it a better 'hold' than a 'buy' prospect. Read the full article on Seeking AlphaSeeking Alpha • Jun 30
IDEX: Order Moderation Illuminating A Path Forward
Summary Order moderation in Q1 FY24 indicates initial recovery in end-markets and completion of inventory destocking. IDEX reaffirmed full-year guidance of 0%-2% organic revenue growth, anticipating end-market recovery in the second half of FY24. I predict 7% organic revenue growth from FY25 onwards, with fair value estimated at $220 per share. Read the full article on Seeking AlphaSeeking Alpha • Apr 20
Ensemble Capital - IDEX Corp: A Mundane Company Ready To Fire On All Cylinders
Summary IDEX is not well-known is because it sells decidedly mundane, typically niche parts and technology. We believe, however, that IDEX is among a class of companies that can outperform via acquisitions. IDEX has proven its ability to generate attractive returns from acquisitions in the past, and this could bode well for its chance to further compound shareholder value. Read the full article on Seeking Alpha株主還元
| IEX | US Machinery | US 市場 | |
|---|---|---|---|
| 7D | 0.07% | 0.2% | 1.2% |
| 1Y | 16.2% | 41.3% | 28.7% |
業界別リターン: IEX過去 1 年間で41.3 % の収益を上げたUS Machinery業界を下回りました。
リターン対市場: IEXは、過去 1 年間で28.7 % のリターンを上げたUS市場を下回りました。
価格変動
| IEX volatility | |
|---|---|
| IEX Average Weekly Movement | 3.6% |
| Machinery Industry Average Movement | 6.7% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.1% |
安定した株価: IEX 、 US市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。
時間の経過による変動: IEXの 週次ボラティリティ ( 4% ) は過去 1 年間安定しています。
会社概要
| 設立 | 従業員 | CEO（最高経営責任者 | ウェブサイト |
|---|---|---|---|
| 1987 | 8,700 | Eric Ashleman | www.idexcorp.com |
IDEXコーポレーションは、その子会社とともに、米国、北米、欧州、アジア、および国際的に応用ソリューションを提供している。3つのセグメントで事業を展開している：ヘルス＆サイエンス・テクノロジー（HST）、フルイド＆メータリング・テクノロジー（FMT）、ファイア＆セーフティ／ダイバーシファイド・プロダクツ（FSDP）。HST部門では、精密流体工学、容積式ポンプ、粉体・液体処理技術、乾燥システム、超精密部品、空気圧部品およびシーリング・ソリューション、高性能成形・押出シーリング部品、カスタム・メカニカルシールおよびシャフトシールなどを設計、製造、販売している。また、人工衛生ミキサー・バルブ、生体適合性医療機器・埋め込み型製品、エアコンプレッサー・送風機、光学部品・コーティング、超精密ダイヤモンド工具、研究用・業務用機器、精密フォトニクス・ソリューション、テクニカルセラミックス、気密封止製品、多孔質材料構造、流量制御ソリューションなども提供している。FMT部門は、容積式ポンプ、バルブ、小容量プローバー、流量計、インジェクター、その他の流体処理ポンプモジュール、システムの設計、製造、販売、および流量モニタリングやその他のサービスを提供している。FSDP事業では、消防ポンプ、バルブ、制御装置、救助用具、吊り上げ用バッグ、その他の部品およびシステム、ステンレス鋼製バンドおよびクランプ装置、着色剤および塗料の分注、計量、混合用の精密機器の設計、製造、販売を行っている。1987年に法人化され、イリノイ州ノースブルックに本社を置く。
IDEX Corporation 基礎のまとめ
| IEX 基礎統計学 | |
|---|---|
| 時価総額 | US$15.45b |
| 収益（TTM） | US$507.70m |
| 売上高(TTM) | US$3.53b |
30.4x
PER（株価収益率4.4x
P/SレシオIEX は割高か？
公正価値と評価分析を参照収益と収入
| IEX 損益計算書（TTM） | |
|---|---|
| 収益 | US$3.53b |
| 売上原価 | US$1.96b |
| 売上総利益 | US$1.57b |
| その他の費用 | US$1.06b |
| 収益 | US$507.70m |
直近の収益報告
Mar 31, 2026
次回決算日
該当なし
| 一株当たり利益（EPS） | 6.86 |
| グロス・マージン | 44.44% |
| 純利益率 | 14.38% |
| 有利子負債／自己資本比率 | 46.2% |
IEX の長期的なパフォーマンスは？
過去の実績と比較を見る| IDEX 配当日 | |
|---|---|
| 配当落ち日 | May 22 2026 |
| 配当支払日 | Jun 05 2026 |
| 配当落ちまでの日数 | 4 days |
| 配当支払日までの日数 | 10 days |
IEX 配当は確実ですか？
IEX 配当履歴とベンチマークを見る企業分析と財務データの現状
| データ | 最終更新日（UTC時間） |
|---|---|
| 企業分析 | 2026/05/25 04:23 |
| 終値 | 2026/05/22 00:00 |
| 収益 | 2026/03/31 |
| 年間収益 | 2025/12/31 |
データソース
企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。
| パッケージ | データ | タイムフレーム | 米国ソース例 |
|---|---|---|---|
| 会社財務 | 10年 |
| |
| アナリストのコンセンサス予想 | +プラス3年 |
|
|
| 市場価格 | 30年 |
| |
| 所有権 | 10年 |
| |
| マネジメント | 10年 |
| |
| 主な進展 | 10年 |
|
* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。
特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。
分析モデルとスノーフレーク
本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。
シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。
業界およびセクターの指標
私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。
アナリスト筋
IDEX Corporation 14 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。28
| アナリスト | 機関 |
|---|---|
| John Eade | Argus Research Company |
| Michael Halloran | Baird |
| Walter Liptak | Barrington Research Associates, Inc. |